Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Y14 in overweight/obese subjects with or without type 2 diabetes
NCT03673111Phase 1Completed
- Sponsor
- Imperial College London
- Start
- Apr 2017
- Primary completion
- Feb 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Y14 in obesity and type 2 diabetes mellitus (T2DM), sponsored by Imperial College London. Started Apr 2017; status: completed.
02
Drugs
Y14
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03673111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03673111.